AI-based smartphone apps for risk assessment of skin cancer need more evaluation and better regulation
Research output: Contribution to journal › Article › peer-review
Colleges, School and Institutes
Smartphone applications (“apps”) with artificial intelligence (AI) algorithms are increasingly used in healthcare. Widespread adoption of these apps must be supported by a robust evidence-base and app manufacturers’ claims appropriately regulated. Current CE marking assessment processes inadequately protect the public against the risks created by using smartphone diagnostic apps.
Not yet published as of 02/03/2021
|Journal||British Journal of Cancer|
|Publication status||Accepted/In press - 14 Jan 2021|